Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

NCT03987698 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma

Interventions

BIOLOGICAL: SHR-1210
BIOLOGICAL: CIK cells

Sponsor

Tianjin Medical University Cancer Institute and Hospital